Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol., 20 October 2025

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1721980

Correction: The germinal center-tertiary lymphoid structure after neoadjuvant chemo-immunotherapy for locally advanced lung squamous cell carcinoma can predict the disease progression

This article is a correction to:

  1. The germinal center-tertiary lymphoid structure after neoadjuvant chemo-immunotherapy for locally advanced lung squamous cell carcinoma can predict the disease progression

    1. Read original article
Shuang Li,Shuang Li1,2Ping ZhouPing Zhou1Yan Huang,Yan Huang3,4Min ChenMin Chen1Chan YangChan Yang1Lili Jiang*Lili Jiang1*
  • 1Department of Pathology, West China Hospital, Sichuan University, Chengdu, China
  • 2Department of Pathology, The First People’s Hospital of Yunnan Province, Yunnan, Kunming, China
  • 3Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
  • 4College of Physical Education and Health Science, Yi bin University, Yi bin, Sichuan, China

A Correction on
The germinal center-tertiary lymphoid structure after neoadjuvant chemo-immunotherapy for locally advanced lung squamous cell carcinoma can predict the disease progression

By Jiang L, Li S, Zhou P, Huang Y, Chen M and Yang C (2025). Front. Immunol. 16:1579840. doi: 10.3389/fimmu.2025.1579840

In the published article, there was an error in the author list, and author “Shuang Li” was erroneously sorted. The corrected author list appears below.

“Shuang Li 1,2, Ping Zhou1, Yan Huang3,4, Min Chen1, Chan Yang1 and Lili Jiang1*”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: neoadjuvant chemoimmunotherapy, lung squamous cell carcinoma, prognostic biomarkers, tertiary lymphoid structures (TLSs), neoadjuvant chemotherapy

Citation: Li S, Zhou P, Huang Y, Chen M, Yang C and Jiang L (2025) Correction: The germinal center-tertiary lymphoid structure after neoadjuvant chemo-immunotherapy for locally advanced lung squamous cell carcinoma can predict the disease progression. Front. Immunol. 16:1721980. doi: 10.3389/fimmu.2025.1721980

Received: 10 October 2025; Accepted: 13 October 2025;
Published: 20 October 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Li, Zhou, Huang, Chen, Yang and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lili Jiang, ODc5ODc2MDQ3QHFxLmNvbQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.